These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 21899)

  • 41. L-tryptophan in neuroleptic-induced tardive dyskinesia.
    Sandyk R; Bamford CR; Khan I; Fisher H
    Int J Neurosci; 1988 Sep; 42(1-2):127-30. PubMed ID: 2905343
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tardive dyskinesia.
    Bsoul SA; Terezhalmy GT; Riley CK; Moore WS
    Quintessence Int; 2002 Apr; 33(4):326-7. PubMed ID: 11989382
    [No Abstract]   [Full Text] [Related]  

  • 43. Tardive dyskinesia rates with atypical antipsychotics in adults: prevalence and incidence.
    Kane JM
    J Clin Psychiatry; 2004; 65 Suppl 9():16-20. PubMed ID: 15189107
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Spontaneous and tardive dyskinesias: clinical and laboratory studies.
    Casey DE
    J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):42-7. PubMed ID: 2858480
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Changing epidemiology of tardive dyskinesia: an overview.
    Jeste DV; Wyatt RJ
    Am J Psychiatry; 1981 Mar; 138(3):297-309. PubMed ID: 6110344
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Risk factors for drug-induced parkinsonism in tardive dyskinesia patients.
    Hansen TE; Brown WL; Weigel RM; Casey DE
    J Clin Psychiatry; 1988 Apr; 49(4):139-41. PubMed ID: 2895762
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Coexistence of severe parkinsonism and tardive dyskinesia as side effects of neuroleptic therapy.
    Bitton V; Melamed E
    J Clin Psychiatry; 1984 Jan; 45(1):28-30. PubMed ID: 6141157
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Markers of glutamatergic neurotransmission and oxidative stress associated with tardive dyskinesia.
    Tsai G; Goff DC; Chang RW; Flood J; Baer L; Coyle JT
    Am J Psychiatry; 1998 Sep; 155(9):1207-13. PubMed ID: 9734544
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A monitoring test for the liability of neuroleptic drugs to induce tardive dyskinesia.
    Gunne LM; Bárány S
    Psychopharmacology (Berl); 1979 Jun; 63(3):195-8. PubMed ID: 39307
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tardive dyskinesia presenting as gastrointestinal disorder.
    Goldberg RJ; Morris PL; Lidofsky S
    J Clin Psychiatry; 1990 Jun; 51(6):253-4. PubMed ID: 1971823
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Early extrapyramidal side-effects as risk factors for later tardive dyskinesia: a prospective study.
    Sachdev P
    Aust N Z J Psychiatry; 2004 Jun; 38(6):445-9. PubMed ID: 15209837
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical Spectrum of Drug-Induced Movement Disorders: A Study of 97 Patients.
    Chouksey A; Pandey S
    Tremor Other Hyperkinet Mov (N Y); 2020 Oct; 10():48. PubMed ID: 33178486
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Factors related to tardive dyskinesia.
    Chouinard G; Annable L; Ross-Chouinard A; Nestoros JN
    Am J Psychiatry; 1979 Jan; 136(1):79-82. PubMed ID: 31802
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Vulnerability to tardive dyskinesia.
    Wolf ME; DeWolfe AS; Ryan JJ; Lips O; Mosnaim AD
    J Clin Psychiatry; 1985 Sep; 46(9):367-8. PubMed ID: 2863257
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Nithsdale schizophrenia survey. V. Follow-up of tardive dyskinesia at 3 1/2 years.
    Robinson AD; McCreadie RG
    Br J Psychiatry; 1986 Nov; 149():621-3. PubMed ID: 2880631
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Utility of quetiapine in tardive dyskinesia].
    Navarro Pacheco BV; Montejo González AL; Martín Carrasco M
    Actas Esp Psiquiatr; 2003; 31(6):347-52. PubMed ID: 14639511
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Neuroleptic-induced acute extrapyramidal syndromes and tardive dyskinesia.
    Casey DE
    Psychiatr Clin North Am; 1993 Sep; 16(3):589-610. PubMed ID: 8105453
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Diazepam in tardive dyskinesia.
    Weber SS; Dufresne RL; Becker RE; Mastrati P
    Drug Intell Clin Pharm; 1983; 17(7-8):523-7. PubMed ID: 6135591
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Drug-induced tardive dyskinesia.
    Itoh H
    Curr Dev Psychopharmacol; 1981; 6():93-126. PubMed ID: 6112119
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tardive dyskinesia and treatment of psychosis after withdrawal of neuroleptics.
    Baskett SJ
    Brain Res Bull; 1983 Aug; 11(2):173-4. PubMed ID: 6138132
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.